荧光光谱法研究克仑特罗与蛋白质的结合作用

应用荧光光谱法研究了水溶液中盐酸克仑特罗与牛血清白蛋白分子间的结合反应 ,测定了结合常数 (K =2 .84× 1 0 3 L mol)和结合位点数 (n =5 .65)。依据F ster非辐射能量转移理论 ,确定了授体 受体间的结合距离 (r=1 .69nm)和能量转移效率 ,采用同步荧光技术考察了盐酸克仑特罗对牛血清白蛋白构象的影响。利用盐酸克仑特罗对蛋白质荧光猝灭 ,对作用机理做了初步探讨     

毛细管电泳电化学法分离检测盐酸克伦特罗、特布他林和沙丁胺醇

建立了毛细管电泳电化学法对盐酸克伦特罗、特布他林和沙丁胺醇进行分离检测。方法采用胶束电泳体系,以铂圆盘为工作电极,考察了检测电位、缓冲液浓度和pH、十二烷基硫酸钠(SDS)浓度、分离电压等因素的影响。3个分离物在10 kV的分离电压、缓冲体系为15 mmol/L(pH 9.0)硼砂+20 mmol/L SDS条件下得到分离。盐酸克伦特罗、特布他林和沙丁胺醇的线性范围分别为2.0～400,3.5～700,5.0～1000μg/L。方法已用于猪肉样品的检测。     

酶联免疫法测定猪肉、猪肝和猪尿中盐酸克伦特罗

对4种国产及进口的酶联免疫法测试盒测定猪肉、猪肝及猪尿中克伦特罗残留量的性能及效果作了对比试验。试验时以上述3种样品为基体,加入1,2,3,5,10μg.kg-1(或μg.L-1)等5个浓度水平的克伦特罗标准溶液,然后用上述测试盒进行检测。从所得的结果可知,国内外的测试盒所得测定值间存在较大差异;猪尿样品的检测结果表明这些测试盒所采用的方法比较适合,但由猪肉及猪肝样品的检测结果可知,其中一些测试盒所采用的方法尚有改进的必要。     

测定克喘素免疫偶合物分子结合摩尔比的紫外-可见分光光度法

以牛血清白蛋白（BSA）、卵清白蛋白（OVA）为载体，采用重氮法，制出克喘素（CL）的两种免疫偶合物免疫原CL－BSA和包被抗原CL－OVA；通过紫外光谱定性证明偶合物偶联成功，通过可见光谱法定量测定偶合物的分子结合摩尔比，结果表明CL－BSA与CL－OVA的分子结合摩尔比分别为13．19：1、7．53：1，方法简便快捷，灵敏度高。     

质谱快速分析猪肉中痕量沙丁胺醇及克伦特罗

采用内部萃取电喷雾电离质谱( iEESI-MS)技术,在无需样品预处理的前提下,采用标准加入法直接对猪肉组织中沙丁胺醇与克伦特罗进行定性和定量分析。结果表明,本实验对猪肉组织中沙丁胺醇与克伦特罗具有较高的灵敏度,单个样品单一指标的检测时间少于30 s。在0.01~1000μg/kg浓度范围内,信号强度对数(Y)与浓度对数(X)具有较好的线性关系,定量限分别为6.2和9.8 ng/kg。本方法分析速度快、样本耗量少、灵敏度高,适用于猪肉中痕量沙丁胺醇与克伦特罗等“瘦肉精”的快速检测。     

高效毛细管电泳对克伦特罗对映体的分离及定量检测

以羟丙基-β-环糊精(HP-β-CD)作为手性添加剂,采用毛细管区带电泳(CZE)成功分离了克伦特罗(Clenbuterol,Cle)对映体.研究了β-CD种类与浓度,缓冲液pH值及浓度,操作温度等对分离的影响.结果表明,以30 mmol/L的HP-β-CD为手性添加剂,50 mmol/L的磷酸盐缓冲溶液(pH 2.5)为缓中液,分离电压24 kV,操作温度20℃,可使Cle对映体实现基线分离,其分离度为6.78.对拆分机理也进行了探讨,测定了HP-β-CD与两对映体的结合常数及热力学参数;对CZE定量能力(线性,精度)进行了考察,R和S型的线性相关系数都大于0.998,两者的相对标准偏差(RSD)均低于2.2%.     

Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry

The quantitative determination of clenbuterol in human plasma and urine is of particular interest for various fields such as clinical and forensic research and doping controls. A simple and rapid sample preparation procedure based on liquid-liquid extraction with subsequent re-extraction followed by liquid chromatography and electrospray ionization tandem mass spectrometry allowed the determination of clenbuterol in urine and plasma at detection and quantification limits of 0.1 ng mL⁻¹ and 0.2 ng mL⁻¹, respectively, with recoveries ranging from 85–96%. The fast and robust nature of the assay provides a rapid and cost-effective alternative to established procedures utilizing solid-phase extraction strategies.     

Production of “in house” reference materials for ELISA screening of bovine urine and liver samples for clenbuterol

Clenbuterol screening of bovines is done by analysis of urine, for monitoring living animals, and liver, for monitoring animals after slaughter. ELISA has generally been used as the main method for these purposes. Nevertheless, in Europe, methods must be validated according to Commission Decision (EC) 657/2007 criteria, i.e. by use of reference materials. Production of “in house” reference materials is a possibility, but the homogeneity, storage temperature, and period of stability of these materials must be investigated in the laboratory itself. This paper reports GC–MS evaluation of an “in-house”-produced batch of aliquots of bovine urine and liver, fortified with 10.0 ng/ml and 10.0 ng/g clenbuterol, respectively, and stored at ?20 °C and at ?60 °C. For urine stored for 20 weeks at ?20 °C and at 60 °C the stability of clenbuterol was proved at the 95% confidence level. For liver, however, it was demonstrated at the same confidence level that clenbuterol was highly unstable during storage for 20 weeks at either of the temperatures studied.     

Analysis of β-agonists and β-blockers in urine using hollow fibre-protected liquid-phase microextraction with in situ derivatization followed by gas chromatography/mass spectrometry

A method using hollow fibre-protected liquid-phase microextraction (HF-LPME) with in situ derivatization followed by gas chromatography/mass spectrometry (GC/MS) was established for the analysis of β-agonists and β-blockers in urine. Because it can simultaneously extract and derivatize compounds of interest by methylbenzol and N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) in HF-LPME, the approach overcomes the drawbacks of considerable time-consuming and tedious operation, meanwhile improves enrichment multiple. The optimized conditions were extraction for 20 min at 35 °C with 5.0 μL of mixed extraction solvent (methylbenzol/MSTFA = 1:1, v/v) with stirring speed of 925 rpm in 5.0 mL sample under pH 12.0 and 14% (w/v) NaCl. The method provided very wide linear ranges (0.25–400 ng mL⁻¹) and low detection limits in the range of 0.08–0.10 ng mL⁻¹ for clenbuterol, metoprolol and propranolol while enrichment factors reached up to 256. The analytes could be determined in spiked urine by the method with high extraction efficacy (93.79–109.04% recoveries) and precision (<9.70% RSD). It has a satisfactory result for metoprolol in practical human urine samples for a single-dose administration of 50 mg after 36 h. The proposed method only needs few microliters of organic solvent and derivatizing agent; the operation is simple, convenient and rapid for the trace analysis of β-agonists and β-blockers in biological fluids; it can be readily generalized for high sample throughput. So, it is hopeful that the study will facilitate the monitoring of β-agonists and β-blockers in the competition sports.     

A straightforward route to obtain C1-labeled clenbuterol

Singly-labeled ¹³C₁-clenbuterol has been synthesized employing a straightforward pathway starting from easily available acetanilide. The critical step was the Friedel-Crafts acylation of this compound with marked acetyl chloride, being the first example of the use of this methodology applied to the synthesis of a clenbuterol derivative. Subsequent chemical reactions afforded the desired product with good yields.